High-dose thiotepa and hematopoietic stem cell transplantation in pediatric malignant mesenchymal tumors: A phase II study

Bone Marrow Transplantation

Volumn 26, Issue 6, 2000, Pages 627-632

  Lafay Cousin, L ^a   Hartmann, O ^a   Plouvier, P ^b   Mechinaud F ^c   Boutard, P ^d   Oberlin, O ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b HÔPITAL SAINT JACQUES   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

^d CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

BMT; Children; Rhabdomyosarcoma; Sarcoma; Thiotepa

Indexed keywords

ANTIBIOTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 2; ONDANSETRON; THIOTEPA;

ADOLESCENT; ADULT; ANOREXIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW RESCUE; BONE MARROW SUPPRESSION; BONE MARROW TRANSPLANTATION; CANCER MORTALITY; CANCER REGRESSION; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGIC CYSTITIS; HUMAN; MALE; MALIGNANT NEOPLASTIC DISEASE; MESENCHYMOMA; METASTASIS; MUCOSA INFLAMMATION; NEPHROTOXICITY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SKIN TOXICITY; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

EID: 0033799672     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702573     Document Type: Article

References (27)

1. High-dose N-N'-N″ triethylenethiophosphoramid in pediatric phase I-II autologous bone marrow transplantation studies
2. Phase II of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors
3. An attempt to use a common staging system in rhabdomyosarcoma: A report of an international workshop initated by the International Society of Pediatric Oncology (SIOP)
4. The improvement in survival associated with combined chemotherapy in childhood rhabdomyosarcoma. A historical comparaison of 345 patients in the same center
5. Treatment of non metastatic rhabdomyosarcomas in chilhood and adolescence. Result of the second study of the international society of pediatric oncology: MMT 84
6. Non metastatic rhabdomyosarcoma: Experience from the SIOP MMT 89 study
7. Progress in the treatment of non-metastatic rhabdomyosarcoma (RMS): A report from the SCOP MMT 89 and 95 studies
8. Anti-infective prophylaxis with ceftazidime and teicoplanin in children undergoing high-dose chemotherapy and bone marrow transplantation
9. Regimen related toxicity in patients undergoing bone marrow transplantation
10. Standards options and recommendations for clinical care of rhabdomyosarcoma and others soft tissue sarcoma in children
11. The third intergroup rhabdomyosarcoma study
12. Metastatic rhabdomyosarcoma and histologically similar tumors in childhood: A retrospective European multi-center analysis
13. High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma
14. Autologous stem cell transplantation in solid tumors of childhood
15. High-dose N, N', N″-triethilenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: Phase I studies
16. A phase II study of thiotepa in children with recurrent solid tumor malignancies: A Children's cancer group study
17. Thiotepa and cyclophosphamide with stem cell rescue for consolidation therapy for children with high risk neuroblastoma: A phase I/II study of the pediatric blood and marrow transplant consortium
18. High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: A phase II study
19. High-dose thiotepa with autologous bone marrow rescue in pediatric solid tumors
20. High-dose chemotherapy followed by peripheral blood stem cell rescue for metastatic rhabdomyosarcoma: The experience at Chicago children's memorial hospital
21. Do patients with metastatic and recurrent rhabdomysarcoma benefit from high-dose therapy with hematopoietic rescue?
22. Double conditioning consisting of thiotepa, melphalan and busulfan with stem cell rescue for the treatment of pediatrics solid tumors
23. Megatherapy in childhood sarcoma. A decade of phase II studies: What next
24. Megatherapy with autologous bone marrow rescue in advance rhabdomyosarcoma
25. Autologous bone marrow transplantation in pediatric solid tumors: Phase II studies
26. A phase II trial of high-dose methotrexate in previously untreated children and adolescents with high risk unresectable or metastatic rhabdomyasarcoma
27. Prognostic factors in children with metastatic rhabdomyosarcoma: Results of the European intergroup studies (EIS) MMT'89 and MMT'91